Showing results (361-370 of 393) with videos related to
Sort By:
Pageof 40
JCO Precision Oncology|January 12, 2023
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal CancerRachel B Keller, Tali Mazor, Lynette Sholl, et al.Nature Medicine|January 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trialJun Tian, Jonathan H Chen, Sherry X Chao, et al.The Lancet. Oncology|November 26, 2009
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 studyAndrew X Zhu, Jeffrey A Meyerhardt, Lawrence S Blaszkowsky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2017
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)Charles S Fuchs, Donna Niedzwiecki, Harvey J Mamon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II studyAndrew X Zhu, Dushyant V Sahani, Dan G Duda, et al.Cancer Research|July 4, 2012
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesisAustin M Dulak, Steven E Schumacher, Jasper van Lieshout, et al.European Journal of Neurology|January 26, 2008
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI studyC Wegner, M Filippi, T Korteweg, et al.Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumabRyan J Park, Milan Parikh, Leon Pappas, et al.Neuroimage|June 27, 2008
Reproducibility of fMRI in the clinical setting: implications for trial designsR Bosnell, C Wegner, Z T Kincses, et al.The Lancet. Oncology|February 6, 2019
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trialCharles S Fuchs, Kohei Shitara, Maria Di Bartolomeo, et al.Pageof 40